Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines 2022-05-13 08:30
Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria 2022-05-12 22:43
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress 2022-05-12 22:01
BIORCHESTRA Participated in Formulation and Delivery 2022-05-12 21:00
ECCMID 2022: Copan unveils its WISE approach to sample management 2022-05-12 20:25
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery 2022-05-12 20:00
GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region 2022-05-12 18:26
A novel universal antiviral drug introduced in Korea 2022-05-12 18:19
INFOBAE.COM: Houston doctors and researchers that are making the biggest international impact according to the KOLs list - Most of them are women 2022-05-12 08:22
Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial 2022-05-12 08:00
I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes. 2022-05-12 00:00
Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts. 2022-05-11 22:00
PharmAbcine to participate in Jefferies Global Healthcare Conference and BIO International Convention 2022-05-11 20:00
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates 2022-05-11 15:13
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022 2022-05-11 13:05
Prenetics and Artisan Acquisition Corp. Announce Shareholder Approval of Business Combination, To Begin Trading on Nasdaq on May 18 Under the Ticker "PRE" 2022-05-11 09:00
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients 2022-05-11 08:40
RhoVac AB announces Database Lock in its clinical phase IIb trial of onilcamotide 2022-05-11 06:42
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition 2022-05-11 04:16
Bridge Biotherapeutics to Announce Updated Data from its Phase 1 Study of BBT-176 in Advanced Non-Small Cell Lung Cancer in an Oral Presentation at IASLC 2022 World Conference on Lung Cancer 2022-05-10 21:00
1 176 177 178 179 180 452